NovaScan Inc Press Releases

• Published on April 22, 2025 - 06:42 GMT

  NovaScan’s MarginScan™ Device for Skin Cancer Surgery to Be Featured at AAD Innovation Academy 2025

  Study Involving NovaScan’s Groundbreaking MarginScan™ Intraoperative Cancer Device Selected for Presentation at 2025 AAD Innovation Academy CHICAGO, IL, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- NovaScan, a leader in precision surgical …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on October 22, 2024 - 17:37 GMT

  NovaScan Announces the Appointment of Two Luminary Advisors

  Robert W. Cook, Ph.D. and Robert Zieserl will Become Advisors to the Company CHICAGO, IL, UNITED STATES, October 22, 2024 /⁨EINPresswire.com⁩/ -- NovaScan, a clinical stage oncology company based in Chicago, IL, announced the appointment of two luminary …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 8, 2024 - 13:23 GMT

  NovaScan and Dr Paul Grippo Receive Competitive Award for Pancreatic Cancer Research

  CHICAGO, IL, USA, February 8, 2024 /⁨EINPresswire.com⁩/ -- NovaScan, a clinical-stage oncology company based in Chicago, today announced that a collaboration with Dr Paul Grippo, Associate Professor of Gastroenterology and Hepatology at the University of …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on August 1, 2023 - 19:59 GMT

  NovaScan Announces Launch of its nsCanary™ Lung Trial at University of Chicago

  Principal Investigator Dr Kyle Hogarth will lead the trial CHICAGO, IL, USA, August 1, 2023 /⁨EINPresswire.com⁩/ -- NovaScan, a clinical-stage oncology company based in Chicago, announced that it has received IRB approval to commence a clinical trial …

  Distribution channels: Companies, Electronics Industry ...
• Published on January 9, 2023 - 15:21 GMT

  NovaScan Announces the Launch of a Human GI trial for its nsCanary™ Cancer Detection Device

  CHICAGO, IL, USA, January 9, 2023 /⁨EINPresswire.com⁩/ -- NovaScan, a clinical stage oncology company based in Chicago, announced that it has started a human GI clinical trial for its nsCanary™ device at Texas International Endoscopy Center (TIEC), led by …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on August 9, 2022 - 21:32 GMT

  Dr Amit Mehta to Advise NovaScan on Ex Vivo Scanning Product

  CHICAGO, IL, USA, August 9, 2022 /⁨EINPresswire.com⁩/ -- NovaScan, an emerging oncology company based in Chicago, has announced that Dr Amit Mehta will guide NovaScan on the development of its ex vivo offerings for both gastroenterology and pulmonology. Dr …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on May 2, 2022 - 17:46 GMT

  NovaScan announces Luminary Scientific Advisory Board Leaders in Pulmonary and Gastroenterology

  CHICAGO, IL, USA, May 2, 2022 /⁨EINPresswire.com⁩/ -- Chicago IL: NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of luminaries in interventional pulmonology and gastroeneterology to lead initiatives in lung and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on November 17, 2021 - 22:36 GMT

  NovaScan Completes $8MM Series B Financing

  CHICAGO, IL, USA, November 17, 2021 /⁨EINPresswire.com⁩/ -- NovaScan, a clinical stage oncology company pioneering a new low cost point of care platform for cancer detection and treatment, announced that it has completed a $8 Million Series B financing, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...